U.S. Healthtech Stock News

Prosperity Bancshares (PB) opened FY 2025 with fourth quarter total revenue of US$317.7 million and basic EPS of US$1.49, alongside net income excluding extra items of US$139.9 million. The trailing 12 month figures show revenue of US$1.25b and EPS of US$5.72 on net income of US$542.8 million. Over recent quarters, the company’s quarterly revenue moved from US$302.8 million in Q3 2024 to US$317.7 million in Q4 2025, with basic EPS increasing from US$1.34 to US$1.49 and trailing 12 month EPS...

Union Pacific (UNP) closed out FY 2025 with Q4 revenue of US$6.1 billion, basic EPS of US$3.12 and net income of US$1.8 billion, alongside trailing twelve month EPS of US$12.00 and net income of US$7.1 billion that frames the scale of the current earnings base. Over the past few quarters, revenue has moved between US$6.0 billion and US$6.2 billion, while quarterly EPS has ranged from US$2.71 to US$3.16, giving investors a clear view of how the top and bottom lines have tracked into the year...

If you are wondering whether Helios Technologies is attractively priced or getting ahead of itself, you are in the right place to size up what the current share price might actually represent. The stock recently closed at US$64.05, with a 30 day return of 17.5% and a 1 year return of 47.7%. These figures can change how investors view both its growth potential and its risks. Recent news around Helios has focused on evergreen coverage of the company and its position in the capital goods space...

Aflac (AFL) has drawn investor interest after being named a Workday Wellness partner, integrating its supplemental health products into an AI-driven benefits platform that aims to refine employer offerings and benefits administration. See our latest analysis for Aflac. The Workday Wellness partnership lands at a time when Aflac’s share price has edged up 1.95% over the past 90 days to US$108.92. Its 1-year total shareholder return of 3.43% and 5-year total shareholder return of 166.62% point...

Adtalem Global Education recently reported quarterly results after the market close, following a period of analyst expectations for continued year-over-year revenue growth and adjusted earnings of US$2.19 per share. An interesting aspect is Adtalem’s consistent pattern of beating Wall Street’s revenue forecasts over the past two years, averaging a 4.3% outperformance per quarter. Next, we’ll examine how Adtalem’s history of outperforming revenue estimates shapes its investment narrative for...

Q2 2026 earnings snapshot and how the story is shifting Avnet (AVT) has just posted Q2 2026 results with revenue of about US$6.3b and basic EPS of US$0.76, alongside net income of US$61.7m, putting a fresh set of numbers behind the recent share price at US$59.96. The company has seen quarterly revenue move from US$5.6b in Q2 2025 to US$6.3b in Q2 2026, while basic EPS has ranged from US$1.00 in Q2 2025 to US$0.76 this quarter, setting the backdrop for investors focused on how earnings power...

Farmers National Banc (FMNB) just wrapped up FY 2025 with fourth quarter revenue of US$46.8 million and EPS of US$0.39, alongside trailing twelve month revenue of US$181.5 million and EPS of US$1.46. Over the last few quarters, the bank has seen revenue move from US$37.2 million in Q3 2024 to US$43.9 million in Q4 2024 and then US$46.8 million in Q4 2025, while quarterly EPS shifted from US$0.23 to US$0.38 and then US$0.39. This has set up a results season in which investors are likely to...

If you are wondering whether BlackLine at around US$51.82 a share still offers value, the key question is how its current price stacks up against what the underlying business might reasonably be worth. The stock has been relatively soft recently, with a 0.2% return over the last 7 days, a 10.1% decline over 30 days, and returns of 3.6% decline year to date, 17.6% decline over 1 year, 29.8% decline over 3 years, and 62.2% decline over 5 years. Recent coverage of BlackLine has focused on its...

Microchip Technology (MCHP) is back in focus after expanding its maXTouch M1 touchscreen controller family for automotive displays, now spanning large 42 inch widescreens through to compact 2 to 5 inch panels. See our latest analysis for Microchip Technology. The stock has picked up strong momentum recently, with a 1 day share price return of 6.81% and a 30 day share price return of 24.18%. The 1 year total shareholder return of 47.80% contrasts with more muted 3 and 5 year total shareholder...

If you are wondering whether Ameren's share price still lines up with its underlying value, or if the recent run leaves limited room for upside, this article is aimed at helping you frame that question clearly. Ameren shares last closed at US$103.58, with a 7 day return of a 0.5% decline, a 30 day return of 3.3%, a year to date return of 2.7%, and a 1 year return of 14.9%, alongside 3 year and 5 year returns of 30.4% and 64.9% respectively. These moves sit against a backdrop where utilities...

Western Alliance Bancorporation (WAL) has capped FY 2025 with fourth quarter total revenue of US$907.9 million and basic EPS of US$2.61, set against trailing twelve month revenue of US$3.3 billion and EPS of US$8.79. Over recent quarters, the bank has seen total revenue move from US$746.8 million in Q1 2025 to US$907.9 million in Q4 2025, while quarterly basic EPS has shifted from US$1.80 to US$2.61 across the same period. This gives investors a clearer line of sight on how earnings are...

Comfort Systems USA recently reported that its project backlog reached about US$9.38 billion, alongside very rapid five-year compounded growth in earnings per share and higher returns on invested capital. This combination of a large, growing backlog and rising capital efficiency points to a business increasingly converting demand into profitable work. Next, we’ll look at how this expanding US$9.38 billion backlog shapes Comfort Systems USA’s investment narrative and future prospects. These...

California BanCorp (BCAL) has just wrapped up FY 2025 with fourth quarter total revenue of US$50.3 million and basic EPS of US$0.51, while on a trailing twelve month basis revenue was US$189 million and EPS came in at US$1.95. Over the past year, the company has seen revenue move from US$105.7 million to US$189 million and EPS shift from US$0.22 to US$1.95 on a trailing basis, alongside a net profit margin that moved to 33.4% from 5.1%. This puts investor attention squarely on the quality and...

NasdaqGS:NDAQ has amended its corporate charter to allow limited officer exculpation. The change became effective in January 2026 after approval by the US Securities and Exchange Commission. The update affects how Nasdaq's officers are legally protected in connection with corporate decisions. NasdaqGS:NDAQ operates one of the major US securities exchanges and a suite of market technology, data, and listing services used by issuers and investors worldwide. Governance decisions at the holding...

MSCI (MSCI) just posted its latest FY 2025 numbers with Q3 revenue of US$793.4 million and basic EPS of US$4.26, alongside a trailing twelve month net margin of 40% compared with 43.1% a year earlier. The company has seen quarterly revenue move from US$707.9 million in Q2 2024 to US$793.4 million in Q3 2025, while basic EPS has gone from US$3.37 to US$4.26 over the same stretch. This sets the backdrop for investors who are tracking how profit margins are holding up. Given the combination of...

Sysco (SYY) has put up another quarter of solid scale, with Q2 2026 revenue of about US$20.8b, basic EPS of US$0.81 and net income excluding extra items of US$389m, while the trailing twelve months show revenue of roughly US$82.6b, EPS of US$3.73 and net income of US$1.80b. Over the last six reported quarters, revenue has ranged between about US$19.6b and US$21.1b, while quarterly EPS has moved between roughly US$0.81 and US$1.10. This sets the backdrop for a story that hinges on how much...

CNB Financial (CCNE) just posted fourth quarter FY 2025 revenue of US$101.9 million and basic EPS of US$1.10, capping off a trailing twelve month run of US$273.3 million in revenue and US$2.50 in EPS that reflects 23.9% earnings growth over the past year. Over that same twelve month stretch, net income reached US$61.4 million, and the bank paired a 3.65% net interest margin with a 61.49% cost to income ratio. Taken together, these figures offer a clear view of how efficiently the bank is...

Why Copart’s New Credit Facility Matters for Shareholders Copart (CPRT) has put a fresh US$1.25b unsecured revolving credit facility in place, replacing its prior agreement and extending available liquidity out to January 2031 with optional one year extensions. The new facility includes multi currency borrowing capacity, swingline and letter of credit sublimits, and dedicated sub facilities for its German, Spanish, and UK subsidiaries, which ties directly into Copart’s expansion focused...

Lennox International (LII) has put another solid quarter on the board for FY 2025, with Q3 revenue of US$1.4 billion, basic EPS of US$7.00 and net income of US$245.8 million setting the tone for this earnings season update. The company has seen quarterly revenue move from US$1.5 billion in Q2 2025 to US$1.4 billion in Q3, while EPS has shifted from US$7.86 to US$7.00 over the same stretch. This gives investors a clean read on how the top and bottom line are tracking through the year. With...

Recently, Wall Street analysts issued a cautious outlook on Red Rock Resorts, pointing to revenue growth projections that trail the broader gaming and leisure sector and expectations for a tighter free cash flow margin. This skepticism, combined with analysts’ view that the company’s returns on capital are not improving, raises questions about how much its valuation can expand without a shift in fundamentals. Next, we’ll explore how this focus on slowing free cash flow momentum may influence...

Madrigal Pharmaceuticals recently reported that its liver disease drug Rezdiffra has reached over US$1.00 billion in annualized sales, while also signing an exclusive global license agreement with Pfizer for ervogastat, a clinical-stage DGAT-2 inhibitor to expand its MASH treatment pipeline. This combination of rapid commercial uptake for Rezdiffra and external pipeline expansion with Pfizer highlights how Madrigal is trying to build a broader franchise in liver disease treatments. We’ll now...

Otis Worldwide (OTIS) opened FY 2025 with third quarter revenue of US$3.7b and basic EPS of US$0.96, alongside trailing 12 month revenue of US$14.3b and EPS of US$3.41 that frame how the latest print fits into the year so far. The company has seen quarterly revenue move from US$3.6b in Q3 2024 to US$3.7b in Q3 2025, while basic EPS shifted from US$1.35 to US$0.96 over the same period. This sets up a picture where top line scale holds steady, and margins do more of the talking for...

Enova International's FY 2025 Earnings Snapshot Enova International (ENVA) has capped FY 2025 with fourth quarter revenue of US$412.9 million and basic EPS of US$3.19, while trailing twelve month EPS sits at US$12.25 on revenue of about US$1.5 billion. The company has seen quarterly revenue move from US$323.5 million in Q3 2024 to US$412.9 million in Q4 2025, with basic EPS over that stretch ranging from US$1.64 to just above US$3 per share. With net margin at 20.7% over the last year versus...

Versant Media Group: Key recent moves and performance snapshot Versant Media Group (VSNT) has drawn fresh attention after recent trading left the stock around $33.59, with a one-month return of about a 28% decline and year-to-date performance also down roughly 28%. See our latest analysis for Versant Media Group. The recent 1-day and 7-day share price returns of 1.27% and 3.55% sit against a 30-day and year to date share price return of about a 28% decline. This suggests short term momentum...